{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:10:20Z","timestamp":1759533020783,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Chirurgie Plastique Esth\u00e9tique"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.anplas.2014.09.013","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T20:48:09Z","timestamp":1414442889000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["M\u00e9tastases cutan\u00e9es d\u2019un m\u00e9lanome sur un territoire de radioth\u00e9rapie au niveau du sein\u00a0: traitement par v\u00e9muraf\u00e9nib et chirurgie d\u2019ex\u00e9r\u00e8se large"],"prefix":"10.1016","volume":"61","author":[{"given":"J.","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Montaudi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Courdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Camuzard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Chignon-Sicard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anplas.2014.09.013_bib0005","first-page":"567","article-title":"Cutaneous radiation syndrome: clinical features diagnosis and therapy","volume":"51","author":"Gottlober","year":"2000","journal-title":"Hautarzt"},{"key":"10.1016\/j.anplas.2014.09.013_bib0010","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/09553009014550911","article-title":"The skin: its structure and response to ionizing radiation","volume":"57","author":"Hopewell","year":"1990","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.anplas.2014.09.013_bib0015","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/archderm.135.7.804","article-title":"Eosinophilic, polymorphic and pruritic eruption associated with radiotherapy","volume":"135","author":"Rueda","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anplas.2014.09.013_bib0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0167-8140(95)01548-U","article-title":"Late effects consensus conference: RTOG\/EORTC","volume":"35","author":"Rubin","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.anplas.2014.09.013_bib0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.canrad.2010.03.015","article-title":"Normal tissue tolerance to external beam radiation therapy: skin","volume":"14","author":"Ginot","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.anplas.2014.09.013_bib0030","doi-asserted-by":"crossref","first-page":"116s","DOI":"10.1016\/S1278-3218(01)80017-2","article-title":"L\u00e9sions cutan\u00e9es induites par la radioth\u00e9rapie\u00a0: pr\u00e9vention, traitements","volume":"5","author":"Lorette","year":"2001","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.anplas.2014.09.013_bib0035","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1200\/JCO.2004.07.063","article-title":"Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer","volume":"22","author":"Pommier","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anplas.2014.09.013_bib0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0167-8140(00)00322-4","article-title":"The impact of skin washing with water and soap during breast irradiation: a randomized study","volume":"58","author":"Roy","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.anplas.2014.09.013_bib0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.canrad.2008.07.014","article-title":"The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving traitement for breast cancer. A summary of the result of EORTC 22881\u201310882 \u201cboost versus no boost\u201d trial","volume":"12","author":"Poottmans","year":"2008","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.anplas.2014.09.013_bib0050","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1278-3218(97)82951-4","article-title":"Effets tardifs de la radioth\u00e9rapie mammaire sur la peau et les tissus sous-cutan\u00e9s","volume":"1","author":"Dubray","year":"1997","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.anplas.2014.09.013_bib0055","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0360-3016(94)00423-I","article-title":"Pathophysiology of irradiated skin and breast","volume":"31","author":"Archambeau","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.anplas.2014.09.013_bib0060","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0360-3016(01)01745-X","article-title":"RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck","volume":"51","author":"Spencer","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.anplas.2014.09.013_bib0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/1040-8428(90)90033-O","article-title":"Radiation and chemotherapy sensitizers ans protectors","volume":"10","author":"Coleman","year":"1990","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.anplas.2014.09.013_bib0145","article-title":"BRAF and a BRAF pseudogene are located on 7q in man","volume":"7","author":"Sithanandam","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.anplas.2014.09.013_bib0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.2010-0190","article-title":"Systematic review of medical treatment in melanoma: current status and future prospects","volume":"16","author":"Garbe","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.anplas.2014.09.013_bib0080","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anplas.2014.09.013_bib0085","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.1999.17.9.2745","article-title":"Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma","volume":"17","author":"Chapman","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anplas.2014.09.013_bib0090","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1200\/JCO.2006.06.0483","article-title":"Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group","volume":"24","author":"Bedikian","year":"2006","journal-title":"J Clin Oncol"},{"issue":"Suppl.","key":"10.1016\/j.anplas.2014.09.013_bib0095","doi-asserted-by":"crossref","first-page":"LBA5","DOI":"10.1200\/jco.2011.29.18_suppl.lba5","article-title":"A phase 3 randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) versus DTIC alone as first-line treatment in patients with unresectable stage III or IV melanoma","volume":"29","author":"Wolchok","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anplas.2014.09.013_bib0100","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anplas.2014.09.013_bib0105","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.anplas.2014.09.013_bib0110","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anplas.2014.09.013_bib0115","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anplas.2014.09.013_bib0120","first-page":"15s","article-title":"Phase I study of PLX4032: Proof of concept for V600E BRAF mutation as a therapeutic target in human cancer-ASCO. 2009 ASCO Annual Meeting Abstract","volume":"27","author":"Flaherty","year":"2009","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.anplas.2014.09.013_bib0125","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anplas.2014.09.013_bib0130","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anplas.2014.09.013_bib0135","first-page":"1847","article-title":"Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients","volume":"29","author":"Lissoni","year":"2009","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.anplas.2014.09.013_bib0140","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00042728-200601000-00023","article-title":"Melanocytic nevus with atypical dermoscopic features at the site of radiodermatitis","volume":"32","author":"Arpaia","year":"2006","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.anplas.2014.09.013_bib0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma. METRIC Study Group","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Annales de Chirurgie Plastique Esth\u00e9tique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0294126014001733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0294126014001733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:33:34Z","timestamp":1759530814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0294126014001733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0294126014001733"],"URL":"https:\/\/doi.org\/10.1016\/j.anplas.2014.09.013","relation":{},"ISSN":["0294-1260"],"issn-type":[{"type":"print","value":"0294-1260"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9tastases cutan\u00e9es d\u2019un m\u00e9lanome sur un territoire de radioth\u00e9rapie au niveau du sein\u00a0: traitement par v\u00e9muraf\u00e9nib et chirurgie d\u2019ex\u00e9r\u00e8se large","name":"articletitle","label":"Article Title"},{"value":"Annales de Chirurgie Plastique Esth\u00e9tique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anplas.2014.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}